Biotech

All Articles

Metsera associate with Amneal to latch down GLP-1 source

.With early period 1 information right now out in the wild, metabolic disease attire Metsera is actu...

Rivus posts data to support muscle-sparing weight problems drug insurance claims

.Rivus Pharmaceuticals has unveiled the information responsible for its own phase 2 weight problems ...

BMS pays for $110M to create T-cell therapy pact, aiding Prime get opportunity to improve prioritized pipe

.Bristol Myers Squibb is actually paying Prime Medicine $110 thousand in advance to create reagents ...

Generate increases another $1B-plus Big Pharma collaboration

.Novartis has actually tattooed an offer likely worth greater than $1 billion along with Flagship-fo...

Metsera GLP-1 data slice discloses 7.5% fat burning at 36 days

.Just recently debuted Metsera is actually unfolding some period 1 data for its GLP-1 receptor agoni...

Flagship really hopes biotechs flock to Mirai to boost genetic medications

.Among the hereditary medications branches ethnicity, Flagship Pioneering is actually introducing a ...

BioAge eyes $180M coming from IPO, private positioning for obesity trials

.BioAge Labs is checking out all around $180 million in preliminary profits from an IPO as well as a...

Merck's LAG-3 combination fails colon cancer phase 3 research

.An effort through Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic colon cancer...

Spanish VC closes $200M lifestyle sciences fund

.Spain-based Asabys Partners has finalized a fund of 180 thousand europeans ($ 200 thousand), cash t...

BioAge introduces $198M coming from IPO as obesity biotech joins Nasdaq

.BioAge Labs is actually introducing virtually $200 million by means of its Nasdaq IPO today, along ...